← Back to headlines
FTC monitoring how Big Pharma reacts to upcoming patent cliffs, official says
An official from the Federal Trade Commission (FTC) stated that the agency is monitoring how major pharmaceutical companies are reacting to upcoming patent expirations.
18 Mar, 11:39 — 18 Mar, 11:39
Sources
Showing 1 of 1 sources
